Uptodate renewal request

Active Purchase Order Awarded Last action

Contract number
19AQMM23P0306
Awardee
Awarding agency
Obligated
$887,868

Award facts

Opportunity
  • BUY1130770 Solicitation number
Contract value 78% obligated
  • $887,868.00 Current, with exercised options
  • $1,138,428.00 Potential, with all options
Completion date 73% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
Bureau of Medical Services Department of State
NAICS code
513199 All Other Publishers
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
San Antonio, TX 78216, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00004 · Modification to exercise and fund an option $238,436
Exercise an Option P00003 · Exercise option year 2 $227,120
Exercise an Option P00002 · Exercise option year 1 $216,208
Other Administrative Action P00001 · MOD to incorporate far clauses to include 52.204-30. $0
Original award $206,104

About this award

The Bureau of Medical Services awarded a renewal modification to Nationwide Pharmaceutical LLC (doing business as Medical Wholesale) to exercise and fund an option under an existing purchase order, with a ceiling value of $1.14M and an ultimate completion date of March 3, 2028. Nationwide Pharmaceutical, a veteran-owned and service-disabled veteran-owned small business based in San Antonio, Texas, specializes in pharmaceutical distribution and related services for federal healthcare organizations. No set-aside designation was used for this particular award, though the vendor's broader contract portfolio frequently includes small business set-asides. The firm-fixed-price contract calls for pharmaceutical products and medical supplies to support federal healthcare system operations.

This award represents a continuation of Nationwide Pharmaceutical's significant presence as a pharmaceutical supplier across multiple federal agencies, including the Department of Veterans Affairs, Centers for Disease Control and Prevention, Defense Health Agency, and Bureau of Prisons. The company maintains an existing Multiple Award Federal Supply Schedule contract valued at $960K through April 2026, which enables task orders for pharmaceutical products, drugs, and hematology-related items under Schedule 65 I B. The current renewal modification extends the company's ability to provide comprehensive pharmaceutical solutions, including prescription medications, over-the-counter drugs, medical equipment, and clinical support resources to consolidated mail outpatient pharmacies and other federal healthcare facilities.

Quick answers

Who was awarded contract 19AQMM23P0306?

19AQMM23P0306 was awarded to Nationwide Pharmaceutical LLC by Office of Acquisition Management (Department of State) on March 4, 2023.

How much is contract 19AQMM23P0306 worth?

The government has obligated $887,868 on 19AQMM23P0306. Its potential value, with all options, is $1,138,428.

Which agency awarded contract 19AQMM23P0306?

Office of Acquisition Management (Department of State) awarded 19AQMM23P0306, with funding from Bureau of Medical Services (Department of State).

Was contract 19AQMM23P0306 competed?

The extent of competition for 19AQMM23P0306 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award